An overview of international incentive policies on orphan drug research and development and its inspiration to China / 国际药学研究杂志

ABSTRACT

A series of incentive policies have been developed by many foreign governments to encourage pharmaceutical companies to develop orphan drugs that have a small market and high research risk. Taking the United States, the European Union and Japan as the representatives, this paper reviews the international management experiences and incentive policies on orphan drug research and development. Current research and development status of orphan drugs in China is also briefly introduced. Based on international experience, some suggestions are put forward on the development of orphan drug research policy in China, in hope of providing references for promoting the establishment of orphan drug incentive policies in our country.